NAD+ Side Effects NAD+ via subcutaneous injection is generally well tolerated
Together, these pathways highlight how brain health depends on flexible, well-connected neural networks, and why BDNF-related differences may influence how the brain supports cognitive resilience and emotional balance
A post hoc analysis of the phase IIb trial showed that tirzepatide was associated with a reduction in the level of high-sensitivity ICAM-1, CRP, and YKL-40 after 26 weeks of treatment in a dose-dependent manner [83, 103]
In some cases, significant weight loss and energy deficit can lead to functional hypothalamic amenorrhoea, where the brain temporarily reduces signals to the ovaries
A recent study involving 125,474 adults with overweight or obesity, found that 46.5% of patients with Type 2 diabetes and 64.8% of non-diabetics discontinued GLP-1 medications within one year of starting treatment